Hôpital Pierre-Paul Riquet — Toulouse, Midi-Pyrenees

Public research footprint of Hôpital Pierre-Paul Riquet, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Stroke, Ischemic · Parkinson Disease · Myotonic Dystrophy Type 1 (DM1) · CIDP - Chronic Inflammatory Demyelinating Polyneuropathy

Recently updated registry entries

NCT07486934 — Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants… (Recruiting)
NCT07729852 — Open-Label Access to ATH434 for Patients Who Completed Study ATH434-201 in France (Not Yet Recruiting)
NCT07107022 — Study to Collect Real-world Performance and Safety Data on Penumbra System® in Population… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Hôpital Pierre-Paul Riquet?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.